Scientific Exchange: Concepts and Practices in the Field of Electrophysiology
-
10m 57sPart 1 | Session 5 Panel Discussion and Q&A
-
2m 34sPart 2 | Session 1 Welcome
-
15m 37sPart 2 | Session 2 Hemolysis Pathophysiology and Clinical Implications
-
14m 22sPart 2 | Session 3 Hemolysis Incidence Across PFA Technologies
-
14m 57sPart 2 | Session 4 Real-World Experience With PFA and Patient Selection
-
13m 1sPart 2 | Session 5 Panel Discussion and Q&A
-
3m 8sPart 3 | Session 1 Welcome
-
19m 38sPart 3 | Session 2 Lesion Durability and Workflow
-
21m 53sPart 3 | Session 3 Standardized Workflow in a Multi-Operator Center
-
18m 14sPart 3 | Session 4 Panel Discussion and Q&A
-
8m 2sPart 4 | Session 1 Introduction and Insights From Our Experience With PulseSelect
-
15m 1s
-
9m 26sPart 4 | Session 3 Not All PFA Is Created Equal: Discussion
-
17m 17sPart 4 | Session 4 Implementing PulseSelect Into Daily Practice: Learnings and Early Results
-
11m 12sPart 4 | Session 5 Implementing PulseSelect Into Daily Practice: Discussion
-
2m 28sPart 1 | Session 1 Welcome
-
13m 30sPart 1 | Session 2 Review of Affera Mapping and Ablation System and Sphere-9 Catheter
-
20m 39sPart 1 | Session 3 Real-World Experience With Narration of Recorded Affera
Dr Tyler Taigen reviews the clinical data and evidence supporting the use of the Affera™ Mapping and Ablation System.
The Scientific Exchange webinar series features presentations and peer-to-peer discussions with experts on advanced concepts and practices in electrophysiology.
Learning Objectives
- Hemolysis overview: pathophysiology, detection and clinical consequences from a hematologist perspective
- Review recently presented data on durability with PulseSelect PFA Ablation Catheter
- Learn about the latest innovations in pulsed field ablation
Target Audience
- Electrophysiologists
- Cardiologists
- Fellows
- Allied Healthcare Professionals
More from this programme
Part 1
Next Era of Cardiac Ablation: Affera™ Mapping and Ablation System With Sphere-9™ Catheter Real World Experience
Part 2
Hemolysis With Different PFA Technologies: Clinical Considerations
This one-hour session provides a concise and practical overview of hemolysis including its pathophysiology, detection and clinical consequences. Gain actionable insights into hemolysis and PFA technologies through a review of preclinical data as well as real-world strategies for patient selection and procedural optimization.
Part 3
Durability Study With PulseSelect Pulsed Field Ablation (PFA) System and Real-World Experience
This program features presentations and interactive discussion focused on the recently presented data on PulseSelect PFA system and new clinical research on durability with PFA. Faculty also discuss efficiency workflow tips and a multi-user center’s real-world experience.
Part 4
PulseSelect PFA: Rapid Adoption in Everyday Practice With a Dedicated EP Catheter
Learn about the unique value of the PulseSelect PFA system as a dedicated EP technology specifically designed for Pulsed Field Ablation (PFA). Hear from expert users how the PulseSelect technology facilitates easy adoption of PFA into various EP workflows, enabling its daily use with minimal learning curves and consistent performance. See cases-in-the-box featuring practical tips for safe, effective and efficient PFA procedures.
Faculty Biographies
Tyler Taigen
Electrophysiologist
Dr Tyler Taigen is an Electrophysiologist at Cleveland Clinic, Cleveland, US. Dr Taigen is the Co-Director of the Electrophysiology Lab and Director of Quality and Associate Section Head Electrophysiology and Pacing in the Tomsich Family Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute.
Dr Taigen's interests include catheter ablation, management of supraventricular tachycardias, pulmonary vein isolation, left atrial flutter ablation and ventricular tachycardia.